AblationforCardiacArrhythmias near Scranton, PA

Biography: Christopher Irobunda, MD, is an Associate Professor at CUMC and an interventionalist. He is also Vice Chair of the Faculty Development focusing on Diversity, Equity & Inclusion within the Department of Medicine. He trained as a general and interventional cardiologist. Dr. Irobunda has been a full-time faculty since 2003. He obtained his MD/PhD in the Medical Scientist Training Program at the Albert Einstein College of Medicine in the Bronx, NY. His PhD was in Molecular Pharmacology, specifically on the cyclic Adenosine MonoPhosphate/beta-adrenergic signal transduction system. He subsequently completed an internship and residency in internal medicine at New York University Medical Center, followed by his General and Interventional Cardiology Fellowship here at Columbia University Medical Center. After completing his medical training and research study, he shifted his concentration to patient care and the education of aspiring young physicians. Dr. Irobunda is ardently dedicated to uncompromised patient care and teaching. His primary focus is individualized patient care and patient advocacy. Given his training as a medical scientist, it is hardly surprising that he is a keen diagnostician. He has a penchant for complex cardiac issues and other medical problems that can sometimes mask or aggravate the cardiac disease. His aptitude for unraveling these medical conundrums has led to medical diagnoses for patients who have come to him for second and even third opinions. However, above all else, his true genius is his ability to relate to his patients with intelligence, curiosity, patience, compassion, and humor. His ability to waylay even the most apprehensive of patients with his aura of reassurance and understanding has garnered him a continually growing medical practice. Again and again, individuals will refer family members and friends because of the empathy and level of care constantly provided. Indeed, his unceasing diligence has led him to become a physician member of Columbia University Medical Centers Patient Facilitated Services, an organization directed at patient satisfaction and outreach. Dr. Irobunda has also been the primary cardiologist for patients undergoing liver transplant evaluations at New York Presbyterian since 2004. When not in his private practice, he takes great pleasure in helping train the new influx of physicians in the only ethical way to practice medicinepatient-centered care. Dr. Irobunda has been a Supervisor and Attending Faculty for the Fundamentals of Clinical Medicine for First Year Medical Students at Columbia University College of Physicians and Surgeons since 2011, a program that endeavors to instill exceptional patient-doctor communication and trust. He encourages future medical practitioners to listen to the patient and learn to interpret and analyze the information being imported; to realize that the seemingly insignificant details sometimes lead to the culprit of an individual's illness. He has been a lecturer with International Postgraduate Organization for Knowledgetransfer, Research, and Teaching Excellent Students (IPOKRaTES) in Europe. IPOKRaTES offers opportunities for physicians from a plethora of countries to observe and gain instruction regarding differing methods in patient care practices. Since the summer of 2012, Dr. Irobunda has become involved in New York Presbyterian Hospital's Lange Youth Program, which seeks to prepare and enumerate the rigors of medical school for high school students. Dr. Irobunda is active in numerous community outreach organizations-Abyssian Baptist Church (NY), JP Morgan Chase Employee Education Program, Riverside Church Seniors, and Sister to Sister: The Women's Heart Health Foundation, to name a few. He seeks to educate the public on cardiovascular issues and ways to make everyday lifestyle modifications to help reduce these risks. In addition to being an interventional cardiologist who can perform angioplasties and stent placements, he emphasizes the prevention and treatment of heart disease through diet, exercise, and medical therapy.

Biography: Dr. Johanna Contreras, MD is a Clinical Cardiac Electrophysiologist who practices in New York, NY. She is 50 years old and has been practicing for 27 years. Dr. Johanna Contreras, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Michael Benz, MD is a Cardiology Specialist who practices in Jersey City, NJ. He is 58 years old. Dr. Michael Benz, MD is affiliated with Jersey City Medical Center.

Biography: After completing cardiac training at the Cleveland clinic and Umdnj Dr Shehadeh finished advanced his interventional cardiology fellowship at Mount Sinai New York.Dr Shehadeh is a Diplomate of:American Board Internal MedicineAmerican Board of Cardiovascular DiseasesAmerican Board Interventional CardiologyAmerican Board of Endovasvular MedicineAmerican Board of Vascular MedicineNational Board of EchocardiographyAmerican Board of Nuclear CardiologyRegistered Physician In Vascular Interpetation RPVINational Board Of Physicians and Surgeons NBPS

Biography: Dr. Douglas Distefano, MD is a Cardiology Specialist who practices in New York, NY. He is 77 years old and has been practicing for 51 years. Dr. Douglas Distefano, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. S. Chiu Wong is a Professor of Medicine of the Greenberg Division of Cardiology in the Department of Medicine of the Weill Medical College of Cornell University. He is the Director of Cardiac Catheterization laboratories at the NewYork-Presbyterian/Weill Cornell Medical Center.Dr. Wong graduated Summa Cum Laude from Columbia College in May 1980 and received his Doctor of Medicine degree from Columbia University, College of Physicians and Surgeons in May 1984. Following his medical internship, residency, and clinical cardiology training at St. Luke's/Roosevelt Medical Center in New York City, he spent one additional stent fellowship year in 1991 under the tutorage of Dr. Richard Schatz at Scripps's Clinic and Research Foundation in La Jolla, California. He is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.After his medical training, Dr. Wong joined the Cardiology Research Foundation at the Washington Hospital in 1992 and was appointed as Director of Coronary Stent Program in 1993. In 1995, Dr. Wong spearheaded a new cardiac catheterization program at the New York Hospital Medical Center of Queens where he assumed the directorship of coronary interventions. In October 1999, Dr. Wong was recruited to the New York Presbyterian Hospital - Cornell Campus as Director of Cardiac Catheterization Laboratories.Dr. Wong has published extensively in the field of interventional cardiology with special focus on new device angioplasty, saphenous vein graft intervention, cardiogenic shock, and drug eluting stent. His current clinical research interests include novel drug eluting stent designs, access site and PFO closure devices, percutaneous valve repair, and application of stem cell technology in the treatment of myocardial ischemia. In the past five years, Dr. Wong and his colleagues had participated in multiple US pivotal trials that led to the FDA approval of both drug eluting stents for the treatment of symptomatic obstructive coronary artery disease. Dr. Wong has recently served as the national principal investigation in the ECLIPSE trial which evaluated the safety and efficacy of an extra-vascular bio-degradable access site closure device in patients undergoing coronary or peripheral diagnostic/interventional procedures compare to the standard treatment of manual compression.Other exciting areas of ongoing research include percutaneous treatment valvular disease states including mitral regurgitation and aortic stenosis, assessment of novel pharmacologic agents to enhance safety of angioplasty procedures.His clinical research activities have been published in Journal of American College of Cardiology, American Journal of Cardiology, American heart Journal and he has presented his findings at numerous national and international meetings including American Heart Association, American College of Cardiology, Transcatheter Therapeutics, Summer in Seattle, Taiwan Society of Cardiology and Asia Pacific Cardiology Congress. He is recruited to serve as member of the Scientific Advisory Board of multiple major US medical device companies.

Care Philosophy: nbsp;To achieve the best possible patient outcomes Dr Russo uses leading edge technologies including minimally invasive endovascular and hybrid approaches; transcatheter valve replacement TAVR ; valve sparing aortic procedures; and advanced card Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.